Discontinuation report PEGALAX
| Report ID | 200635 |
| Drug Identification Number | 02328232 |
| Brand name | PEGALAX |
| Common or Proper name | polyethylene glycol 3350 |
| Company Name | ARALEZ PHARMACEUTICALS CANADA INC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | POLYETHYLENE GLYCOL 3350 |
| Strength(s) | 100% |
| Dosage form(s) | POWDER FOR SOLUTION |
| Route of administration | ORAL ORAL |
| Packaging size | carton containing 14 sachets (17 grams each) |
| ATC code | A06AD |
| ATC description | DRUGS FOR CONSTIPATION |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | 2023-08-01 |
| Actual discontinuation date | 2023-08-01 |
| Remaining supply date | 2023-08-01 |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | Last inventory shipped today |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 6733 MISSISSAUGA RD MISSISSAUGA, ONTARIO CANADA L5N 6J5 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v3 | 2023-08-02 | English | Compare |
| v2 | 2023-08-01 | French | Compare |
| v1 | 2023-08-01 | English | Compare |
Showing 1 to 3 of 3